Pharmacokinetic/pharmacodynamic modeling to predict in vivo effectiveness of various dosing regimens of piperacillin/tazobactam and piperacillin monotherapy against gram-negative pulmonary isolates from patients managed in intensive care units in 2002

Christopher R. Frei, David S. Burgess

    Research output: Contribution to journalArticlepeer-review

    6 Scopus citations

    Fingerprint

    Dive into the research topics of 'Pharmacokinetic/pharmacodynamic modeling to predict in vivo effectiveness of various dosing regimens of piperacillin/tazobactam and piperacillin monotherapy against gram-negative pulmonary isolates from patients managed in intensive care units in 2002'. Together they form a unique fingerprint.

    Medicine & Life Sciences